You don’t have to bash Nader to make your point. In fact your point is wrong anyway.
RTB said:
Yes, we have "around" 5-6x times the cash that we had before. Like around Feb 29, 2020, when we had $7 million.
What Nader actually said and I quote:
“We have more cash on hand than we ever had by far 5-6 times more than we ever had the highest level.”
Find it at the 7:06-7:15 mark on this video.
https://youtu.be/brLQBARijn0
Now, this leads me to think that you go back and look at the highest month and not the lowest month. That’s what I did. I am not in total belief of that to be true but I am not ok with you slamming Nader for it either.
Nader in my opinion is leading this company into a international market and doing it with substantial partners in heavily populated countries that are peaking in Covid cases. Now these countries have big pharmaceutical companies seeking our MAB for use to help the pandemic that is ripping their countries apart right now. Nader in my view has made some important cross roads happen in short order with these agreements with the 3 current and possibly 2 more strong international pharmaceutical companies he mentioned in Latin America/ Middle East and Europe. I would say that Nader is doing a bang up job of getting our drug ready to sell world wide once we can show results. The Long Hauler trial should help with hopefully excellent results. But the Brazil trial is everything and hopefully interim results show how well Leronlimab works and is enough to start EUA’s across all countries internationally.
Nader and management have set us up nicely to succeed. We are primed and ready for results that will allow us huge marketing deals before the end of the year if we have great interim results. Could we ask for more from Nader right now? It’s up to Leronlimab to have great results now. Then we are blasting of with billions in revenue.
So there is no room to slam Nader. He is a rock star right now in my opinion. Just for choosing the right path and going international at the right time. Huge decisions and I see it working for all of us! Even you RTB. So please don’t slam an excited Nader. He deserves to be excited about the work they have put in acquiring these deals.
Who really knows how much monies we have in reserve. I am betting it is way more than you think and a lot less than my previous posts. But the way you framed your original post was we were going broke in a few short months and there is nothing of the sort happening in my opinion. Especially when you have 88 million shares in CYDY sitting in reserve and a frugal CEO that may not even need to touch them before major revenue is achieved. Now… you gotta love Nader for his ability to not dilute the stock My hope is now…if we are lucky enough to have Leronlimab show well in the Brazil trial. We are set for a huge launch and all the ducks are lining up.
Go Leronlimab… let our trial results set us free from doubt. Show the world we have something special.
RTB said:
Yes, we have "around" 5-6x times the cash that we had before. Like around Feb 29, 2020, when we had $7 million.
What Nader actually said and I quote:
“We have more cash on hand than we ever had by far 5-6 times more than we ever had the highest level.”
Find it at the 7:06-7:15 mark on this video.
https://youtu.be/brLQBARijn0
Now, this leads me to think that you go back and look at the highest month and not the lowest month. That’s what I did. I am not in total belief of that to be true but I am not ok with you slamming Nader for it either.
Nader in my opinion is leading this company into a international market and doing it with substantial partners in heavily populated countries that are peaking in Covid cases. Now these countries have big pharmaceutical companies seeking our MAB for use to help the pandemic that is ripping their countries apart right now. Nader in my view has made some important cross roads happen in short order with these agreements with the 3 current and possibly 2 more strong international pharmaceutical companies he mentioned in Latin America/ Middle East and Europe. I would say that Nader is doing a bang up job of getting our drug ready to sell world wide once we can show results. The Long Hauler trial should help with hopefully excellent results. But the Brazil trial is everything and hopefully interim results show how well Leronlimab works and is enough to start EUA’s across all countries internationally.
Nader and management have set us up nicely to succeed. We are primed and ready for results that will allow us huge marketing deals before the end of the year if we have great interim results. Could we ask for more from Nader right now? It’s up to Leronlimab to have great results now. Then we are blasting of with billions in revenue.
So there is no room to slam Nader. He is a rock star right now in my opinion. Just for choosing the right path and going international at the right time. Huge decisions and I see it working for all of us! Even you RTB. So please don’t slam an excited Nader. He deserves to be excited about the work they have put in acquiring these deals.
Who really knows how much monies we have in reserve. I am betting it is way more than you think and a lot less than my previous posts. But the way you framed your original post was we were going broke in a few short months and there is nothing of the sort happening in my opinion. Especially when you have 88 million shares in CYDY sitting in reserve and a frugal CEO that may not even need to touch them before major revenue is achieved. Now… you gotta love Nader for his ability to not dilute the stock My hope is now…if we are lucky enough to have Leronlimab show well in the Brazil trial. We are set for a huge launch and all the ducks are lining up.
Go Leronlimab… let our trial results set us free from doubt. Show the world we have something special.
5
